119 related articles for article (PubMed ID: 23934193)
1. Pleiotropic effect of somatic mutations in the E2F subunit DP-1 gene in human cancer.
Munro S; Oppermann U; La Thangue NB
Oncogene; 2014 Jul; 33(27):3594-603. PubMed ID: 23934193
[TBL] [Abstract][Full Text] [Related]
2. E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit.
Ingram L; Munro S; Coutts AS; La Thangue NB
Cell Death Differ; 2011 Jan; 18(1):122-32. PubMed ID: 20559320
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
4. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
Komori H; Goto Y; Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Sci Rep; 2018 May; 8(1):8438. PubMed ID: 29855511
[TBL] [Abstract][Full Text] [Related]
5. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
de la Luna S; Allen KE; Mason SL; La Thangue NB
EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
[TBL] [Abstract][Full Text] [Related]
6. High Conformational Flexibility of the E2F1/DP1/DNA Complex.
Saad D; Paissoni C; Chaves-Sanjuan A; Nardini M; Mantovani R; Gnesutta N; Camilloni C
J Mol Biol; 2021 Sep; 433(18):167119. PubMed ID: 34181981
[TBL] [Abstract][Full Text] [Related]
7. Subunit composition determines E2F DNA-binding site specificity.
Tao Y; Kassatly RF; Cress WD; Horowitz JM
Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction between DP-1 and p53.
Sørensen TS; Girling R; Lee CW; Gannon J; Bandara LR; La Thangue NB
Mol Cell Biol; 1996 Oct; 16(10):5888-95. PubMed ID: 8816502
[TBL] [Abstract][Full Text] [Related]
9. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo.
Rogers KT; Higgins PD; Milla MM; Phillips RS; Horowitz JM
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7594-9. PubMed ID: 8755520
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of Xenopus laevis DP proteins.
Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
[TBL] [Abstract][Full Text] [Related]
11. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.
Helin K; Wu CL; Fattaey AR; Lees JA; Dynlacht BD; Ngwu C; Harlow E
Genes Dev; 1993 Oct; 7(10):1850-61. PubMed ID: 8405995
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Adhami VM; Afaq F; Ahmad N
Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
[TBL] [Abstract][Full Text] [Related]
14. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
16. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
17. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
Moberg K; Starz MA; Lees JA
Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117
[TBL] [Abstract][Full Text] [Related]
18. A functionally distinct member of the DP family of E2F subunits.
Milton A; Luoto K; Ingram L; Munro S; Logan N; Graham AL; Brummelkamp TR; Hijmans EM; Bernards R; La Thangue NB
Oncogene; 2006 May; 25(22):3212-8. PubMed ID: 16418725
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogenic properties of the DP family of proteins.
Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
Shan B; Farmer AA; Lee WH
Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
